Subscribe To
ENSC / Ensysce Biosciences and Quotient Sciences to Present MPAR(R) Overdose Protection Platform at Upcoming CRS 2023 Annual Meeting and Expo
ENSC News
By Accesswire
September 5, 2023
Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
SAN DIEGO, CA / ACCESSWIRE / September 5, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage company applyi more_horizontal
By Accesswire
June 27, 2023
Ensysce Biosciences and Quotient Sciences to Present MPAR(R) Overdose Protection Platform at Upcoming CRS 2023 Annual Meeting and Expo
Featured Presentation on ‘Development of a Multi-Pill Abuse Resistant Extended-Release Formulation to Prevent Opioid Overdose' SAN DIEGO, CA / ACCES more_horizontal
By InvestorPlace
May 9, 2023
Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today?
Clinical-stage biotechnology firm Ensysce Biosciences (NASDAQ: ENSC ) skyrocketed sharply on Tuesday, with shares at one point gaining 50% before sett more_horizontal
By Accesswire
April 19, 2023
Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development
~ Global QUOTIENT LIFE SCIENCES Webinar Today, April 19, 2023 at 11:30am ET ~ SAN DIEGO, CA / ACCESSWIRE / April 19, 2023 / Ensysce Biosciences, Inc. more_horizontal
By Seeking Alpha
April 6, 2022
Ensysce Biosciences, Inc. (ENSC) CEO Dr. Lynn Kirkpatrick on Corporate Update Call (Transcript)
Ensysce Biosciences, Inc. (ENSC) CEO Dr. Lynn Kirkpatrick on Corporate Update Call (Transcript) more_horizontal
By Accesswire
March 24, 2022
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage b more_horizontal
By Seeking Alpha
December 17, 2021
Ensysce Biosciences: Developing New Class Of Tamper-Proof Powerful Opioids
Ensysce Biosciences is using its proprietary Trypsin-Activated Abuse Protection and Multi-Pill Abuse Resistance to develop tamper-proof, powerful opio more_horizontal
By Seeking Alpha
December 17, 2021
Ensysce Biosciences: Developing New Class Of Tamper-Proof Powerful Opioids
Ensysce Biosciences is using its proprietary Trypsin-Activated Abuse Protection and Multi-Pill Abuse Resistance to develop tamper-proof, powerful opio more_horizontal